Multiomics research

We provide state of the art quantitative proteomics and other multiomics technologies from one of the biggest and most well-equipped mass spectrometry facilities in Europe.

.

  • Analysis of post-translational protein modifications (PTMs) for direct drug targets and for components of drug-modulated signalling pathways, including mapping sites of glycosylation and phosphorylation.
  • Quantitative analysis of drug-induced changes in protein & RNA expression levels in cells, tissues and common clinical samples.
  • Development of biochemical and cellular assay systems for use in drug screening.
  • Protein tagging and immunoprecipitation studies.
  • Interactome analyses.
  • Protein expression and characterisation.
  • Cell and tissue fractionation and chromatography studies.
  • Construction of cell lines expressing reporter constructs.
  • Cell Imaging and FACS analyses.
  • Immunopeptidomic analyses of human tumour and normal adjacent tissues for cancer vaccine development and other suitable immunotherapies.
Solutions

End-to-end multiomics

Sample acquisition

Multiomics research

Data science

Neoantigen discovery

Get in Touch

Our clients gain a more detailed understanding of complex diseases and drug targets, resulting in improved effectiveness of therapies, cost efficiencies at multiple levels and ultimately the realisation of precision therapeutics.

Contact us to talk to our expert team about your requirements.